BTI

SD - British American Tobacco p.l.c. (0001303523) (Filer)

6-K - British American Tobacco p.l.c. (0001303523) (Filer)

6-K - British American Tobacco p.l.c. (0001303523) (Filer)

6-K - British American Tobacco p.l.c. (0001303523) (Filer)

6-K - British American Tobacco p.l.c. (0001303523) (Filer)

6-K - British American Tobacco p.l.c. (0001303523) (Filer)

6-K - British American Tobacco p.l.c. (0001303523) (Filer)

6-K - British American Tobacco p.l.c. (0001303523) (Filer)

Anticipated CMMI Medicare Pilot Program Participation, Regulatory Momentum, and Cost Structure Improvements Position Company for Growth and Pathway to ProfitabilityLOUISVILLE, Colo., March 31, 2026 /CNW/ - (TSX:CWEB) (OTC:CWBHF), Charlotte's Web Holdings, Inc. ("Charlotte's Web" or the "Company"), a botanical wellness innovation company and the market leader in cannabidiol (CBD) hemp extract wellness products, today announced results for the quarter and year ended December 31, 2025. All amounts are expressed in U.S. dollars, unless otherwise stated. SUBSEQUENT MATERIAL EVENTS BA

Transaction Addresses Capital Structure and Supports Near-Term Operating Priorities, Including Anticipated CMMI Medicare Pilot Program ParticipationLOUISVILLE, Colo., March 30, 2026 /CNW/ - (TSX:CWEB) (OTCQB:CWBHF) Charlotte's Web Holdings, Inc., a botanical wellness innovation company and the market leader in cannabidiol ("CBD") hemp extract wellness products, today announced a transaction with BT DE Investments, Inc. ("BAT"), a subsidiary of British American Tobacco plc (NYSE:BTI), comprising two components: (i) amendment and conversion of BAT's outstanding C$75.3 million principal amount (approximately US$54 million) of the convertible debenture, as well as all accrued interest, into comm

6-K - British American Tobacco p.l.c. (0001303523) (Filer)

6-K - British American Tobacco p.l.c. (0001303523) (Filer)

25-NSE - British American Tobacco p.l.c. (0001303523) (Subject)

6-K - British American Tobacco p.l.c. (0001303523) (Filer)

6-K - British American Tobacco p.l.c. (0001303523) (Filer)

6-K - British American Tobacco p.l.c. (0001303523) (Filer)

6-K - British American Tobacco p.l.c. (0001303523) (Filer)

Issued on behalf of Doseology Sciences Inc.VANCOUVER, BC, March 4, 2026 /CNW/ -- USANewsGroup.com News Commentary -- Consumer habits continue to shift, and there's no better example to point at than the rise of pouches. The global oral nicotine pouch market is projected to surge from $5.4 billion in 2024 to over $25 billion by 2030, reflecting a 29.6% CAGR[1]. On top of this, consumer habits are shifting toward tobacco-free formats which are accelerating alongside demand for functional, portable energy delivery systems that eliminate liquid bulk and sugar crashes[2]. This convergence is channeling capital toward consumer goods platforms built around precise dosing, clean ingredients, and mod

6-K - British American Tobacco p.l.c. (0001303523) (Filer)

Organigram shares priced at average C$2.72 per share representing a combination of Top-Up Rights being exercised at C$2.34/share and shares issued in connection with Sanity acquisition priced at C$3.00/share. Organigram Global Inc. (NASDAQ:OGI) (TSX:OGI), (the "Company" or "Organigram"), a leading global cannabis company, today announced that it has entered into a subscription agreement (the "Subscription Agreement") with BT DE Investments Inc. ( "BAT"), a wholly-owned subsidiary of British American Tobacco p.l.c. (NYSE:BTI), in connection with its previously announced proposed acquisition (the "Acquisition") of Sanity Group GmbH ("Sanity" or "Sanity Group"), including shares of Sanity ow

6-K - British American Tobacco p.l.c. (0001303523) (Filer)

6-K - British American Tobacco p.l.c. (0001303523) (Filer)

6-K - British American Tobacco p.l.c. (0001303523) (Filer)

20-F - British American Tobacco p.l.c. (0001303523) (Filer)

6-K - British American Tobacco p.l.c. (0001303523) (Filer)